PLAINSBORO, N.J., March 25, 2014 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) today announced the expansion of its skin and wound product line with the introduction of Integra® Wound Matrix (Thin). Integra Wound Matrix (Thin) has received 510(k) clearance from the United States Food and Drug Administration (FDA) and expects to begin a full market release in the United States in April 2014. Integra’s newest skin product will be featured at the American Burn Association Annual Meeting, March 25 – 28, 2014, in Boston, Massachusetts.
Help employers find you! Check out all the jobs and post your resume.
